FR2116302B1 - - Google Patents

Info

Publication number
FR2116302B1
FR2116302B1 FR7043891A FR7043891A FR2116302B1 FR 2116302 B1 FR2116302 B1 FR 2116302B1 FR 7043891 A FR7043891 A FR 7043891A FR 7043891 A FR7043891 A FR 7043891A FR 2116302 B1 FR2116302 B1 FR 2116302B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7043891A
Other languages
French (fr)
Other versions
FR2116302A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brun Lab SA Le
Original Assignee
Brun Lab SA Le
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brun Lab SA Le filed Critical Brun Lab SA Le
Priority to FR7043891A priority Critical patent/FR2116302A1/fr
Publication of FR2116302A1 publication Critical patent/FR2116302A1/fr
Application granted granted Critical
Publication of FR2116302B1 publication Critical patent/FR2116302B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7043891A 1970-12-07 1970-12-07 8-aminotheophyllines - with coronary - vasodilator bronchodilator diuretic, spasmolytic, antiinflammatory and analgesic activity Granted FR2116302A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7043891A FR2116302A1 (en) 1970-12-07 1970-12-07 8-aminotheophyllines - with coronary - vasodilator bronchodilator diuretic, spasmolytic, antiinflammatory and analgesic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7043891A FR2116302A1 (en) 1970-12-07 1970-12-07 8-aminotheophyllines - with coronary - vasodilator bronchodilator diuretic, spasmolytic, antiinflammatory and analgesic activity

Publications (2)

Publication Number Publication Date
FR2116302A1 FR2116302A1 (en) 1972-07-13
FR2116302B1 true FR2116302B1 (enExample) 1974-06-21

Family

ID=9065324

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7043891A Granted FR2116302A1 (en) 1970-12-07 1970-12-07 8-aminotheophyllines - with coronary - vasodilator bronchodilator diuretic, spasmolytic, antiinflammatory and analgesic activity

Country Status (1)

Country Link
FR (1) FR2116302A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558162B1 (fr) * 1984-01-17 1986-04-25 Adir Nouveaux derives de la xanthine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
US6821978B2 (en) 2000-09-19 2004-11-23 Schering Corporation Xanthine phosphodiesterase V inhibitors
CN1315835C (zh) 2001-08-28 2007-05-16 先灵公司 多环鸟嘌呤磷酸二酯酶v抑制剂
US6943171B2 (en) 2001-11-09 2005-09-13 Schering Corporation Polycyclic guanine derivative phosphodiesterase V inhibitors
CA2836463A1 (en) 2011-05-17 2012-11-22 Discoverybiomed Inc. Treating protein folding disorders with small molecule cftr correctors
WO2014081821A2 (en) * 2012-11-20 2014-05-30 Discoverybiomed, Inc. Small Molecule Bicyclic and Tricyclic CFTR Correctors
US9676779B2 (en) 2012-11-20 2017-06-13 Discoverybiomed, Inc. Small molecule CFTR correctors
CN120938951A (zh) * 2025-10-17 2025-11-14 湖南绅泰春制药股份有限公司 一种茶碱缓释片及其制备方法和应用

Also Published As

Publication number Publication date
FR2116302A1 (en) 1972-07-13

Similar Documents

Publication Publication Date Title
AR204384A1 (enExample)
ATA96471A (enExample)
AU2044470A (enExample)
AU1146470A (enExample)
AU1473870A (enExample)
AU2085370A (enExample)
AU1336970A (enExample)
AU2130570A (enExample)
AU2017870A (enExample)
AU1833270A (enExample)
AU1716970A (enExample)
AU1517670A (enExample)
AU1326870A (enExample)
AU442398B2 (enExample)
AU1603270A (enExample)
AU1872870A (enExample)
AU1343870A (enExample)
AU1328670A (enExample)
ATA672271A (enExample)
AU2144270A (enExample)
AU2131570A (enExample)
AU1277070A (enExample)
AU1581370A (enExample)
AU1591370A (enExample)
AU1247570A (enExample)

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse